Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Farmobile lawsuit claims dismissed, CEO says ‘Truth won out and justice was served’
A more than two-year legal dispute over trade secrets has hit a milestone, Farmobile announced Friday, as a federal judge dismissed all claims against the Leawood-based farm data firm. “We welcome the court’s decision. Truth won out and justice was served,” said Jason Tatge, CEO of Farmobile. “Farmobile takes great pride in the development of…
Edcoda founder after pivot to new edtech app Boddle: ‘I wish I had failed faster’
Clarence Tan held onto his startup Edcoda longer than he should have, the founder admitted, but his pivot to a new edtech learning app, Boddle, should prove a more filling fit for users. “Boddle has a much better underlying vision and mission, as well as being better in terms of how it would work in…
New STEAM Studio ‘pop-up’ lab planned for Rockhurst library along Troost
With its quiet atmosphere and stacks of source materials, the bottom floor of the Greenlease Library at Rockhurst University is a great place to study or do research. But it doesn’t necessarily strike one as a state-of-the-art design thinking and learning lab — yet. Starting this summer, that section of the university’s library will be…
City: Best way to avoid tickets in downtown KCMO, Crossroads? Pay via ParkMobile app
Unsafe parking conditions in the city’s downtown business districts have spun out of control, prompting increased ticketing, said Matt Staub. The ParkMobile app can reduce such headaches for motorists searching for an open spot along busy Kansas City streets. “People are kind of making up their own parking spaces, parking in ‘no-parking’ zones — all…